News
As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a ...
The University of Hong Kong (HKU) has launched a clinical trial for a gene-related therapy aimed at treating chronic ...
Hepatitis A infection requires understanding symptoms, prevention strategies, and recovery management for effective treatment and lifelong immunity development.
Hepatitis B is relatively frequent in the Bouaké military region, with a prevalence of 5.23%. It predominantly affects ...
Artenie and colleagues presented the first global, regional and national estimates of hepatitis C virus incidence among ...
The University of Hong Kong’s Faculty of Medicine said on Thursday that one of its 41 drugs under clinical trials for Hepatitis B may provide a cure ...
Barwon Health is using a new outreach program to try to identify people living with undiagnosed hepatitis C. Hepatitis C is a bloodborne virus that affects the liver and can cause chronic liver ...
China has made significant strides in controlling hepatitis B virus (HBV) infection over the past three decades, reducing the prevalence of hepatitis ...
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
A large-scale study tracing human disease history back 37,000 years has identified harmful bacteria, viruses and parasites ...
Researchers in gastroenterology and hepatology at HKUMed are pioneering gene-related therapy for chronic hepatitis B infection, potentially enabling ...
SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results